SLNSW-Phase II study of the PI3K inhibitor BKM120 in pa...-TN_cdi_proquest_journals_1865215173

Phase II study of the PI3K inhibitor BKM120 in patients with advanced or recurrent endometrial carcinoma: a stratified type I-type II study from the GINECO group

Full title: Phase II study of the PI3K inhibitor BKM120 in patients with advanced or recurrent endometrial carcinoma: a stratified type I-type II study from the GINECO group

Author/creator: Heudel, P-E, Fabbro, M, Roemer-Becuwe, C, Kaminsky, M C, Arnaud, A, Joly, F, Roche-Forestier, S, Meunier, J, Foa, C, You, B, Priou, F, Tazi, Y, Floquet, A, Selle, F, Berton-Rigaud, D, Lesoin, A, Kalbacher, E, Lortholary, A, Favier, L, Treilleux, I, Ray-Coquard, I.

Call Numbers:

Record Identifier: TN_cdi_proquest_journals_1865215173

Language: English

Formats: Articles

Publishers: England: Nature Publishing Group

Permalink: https://collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_1865215173

Articles

Articles

Export this record

Export selected records

  • Export to excel
  • Permalink

    • Export record to excel

    File type to download

    Beta version

    Record title

    Phase II study of the PI3K inhibitor BKM120 in patients with advanced or recurrent endometrial carcinoma: a stratified type I-type II study from the GINECO group

    Record identifier

    TN_cdi_proquest_journals_1865215173

    Record permalink

    https://collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_1865215173

    Share

    Phase II study of the PI3K inhibitor BKM120 in patients with advanced or recurrent endometrial carcinoma: a stratified type I-type II study from the GINECO group

    ACCESS
    https://collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_1865215173

    Phase II study of the PI3K inhibitor BKM120 in patients with advanced or recurrent endometrial carcinoma: a stratified type I-type II study from the GINECO group

    Full title

    Phase II study of the PI3K inhibitor BKM120 in patients with advanced or recurrent endometrial carcinoma: a stratified type I-type II study from the GINECO group

    Author / Creator

    Heudel, P-E ; Fabbro, M ; Roemer-Becuwe, C ; Kaminsky, M C ; Arnaud, A ; Joly, F ; Roche-Forestier, S ; Meunier, J ; Foa, C ; You, B ; Priou, F ; Tazi, Y ; Floquet, A ; Selle, F ; Berton-Rigaud, D ; Lesoin, A ; Kalbacher, E ; Lortholary, A ; Favier, L ; Treilleux, I ; Ray-Coquard, I

    Publisher

    England: Nature Publishing Group

    Journal title

    British journal of cancer, 2017, Vol.116 (3), p.303-309

    Record Identifier

    TN_cdi_proquest_journals_1865215173

    Language

    English

    Formats

    Articles

    Publication information

    Publisher

    Subjects

    Subjects and topics

    Aged Aged, 80 and over Aminopyridines - therapeutic use Antineoplastic Agents - therapeutic use BKM120 buparlisib Carcinoma, Endometrioid - drug therapy Carcinoma, Endometrioid - pathology Chemotherapy, Adjuvant Clinical Study Disease Progression Endometrial Neoplasms - drug therapy Endometrial Neoplasms - pathology Female Humans metastatic endometrial cancer Middle Aged Morpholines - therapeutic use Neoplasm Recurrence, Local - pathology Phosphatidylinositol 3-Kinases - antagonists & inhibitors PI3K inhibitor Recurrence targeted therapy Treatment Outcome

    More information

    — SCOPE AND CONTENTS

    Contents

    — ALTERNATIVE TITLES

    Full title

    — AUTHORS, ARTISTS AND CONTRIBUTORS

    Author / Creator

    Identifiers

    — PRIMARY IDENTIFIERS

    Record Identifier

    TN_cdi_proquest_journals_1865215173

    Permalink

    https://collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_1865215173

    — OTHER IDENTIFIERS

    ISSN

    E-ISSN

    DOI

    How to access this item

    Online

    1 item

    How to access?

    Login with a Library card

    Full text available >

    About resource >

    View in old catalogue

    Connecting people and collections